Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2218 USD | -7.20% | -13.02% | -7.31% |
04-01 | Transcript : Yield10 Bioscience, Inc., Q4 2023 Earnings Call, Apr 01, 2024 | |
04-01 | Yield10 Bioscience, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Sales 2024 * | 2.25M 3.07M | Sales 2025 * | 4M 5.46M | Capitalization | 3.42M 4.67M |
---|---|---|---|---|---|
Net income 2024 * | -11M -15.02M | Net income 2025 * | -13M -17.75M | EV / Sales 2024 * | 1.52 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.85 x |
P/E ratio 2024 * |
-0.29
x | P/E ratio 2025 * |
-0.26
x | Employees | 29 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.39% |
Latest transcript on Yield10 Bioscience, Inc.
1 day | -7.20% | ||
1 week | -13.02% | ||
Current month | -41.63% | ||
1 month | -40.87% | ||
3 months | +1.37% | ||
6 months | -31.54% | ||
Current year | -7.31% |
Managers | Title | Age | Since |
---|---|---|---|
Oliver Peoples
FOU | Founder | 66 | 92-05-31 |
Charles Haaser
DFI | Director of Finance/CFO | 68 | 07-12-31 |
Kristi Snell
CTO | Chief Tech/Sci/R&D Officer | 56 | 96-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 67 | 06-09-30 | |
Richard Hamilton
BRD | Director/Board Member | 61 | 17-03-01 |
Oliver Peoples
FOU | Founder | 66 | 92-05-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 0.2218 | -7.20% | 331,776 |
24-04-25 | 0.239 | +1.92% | 277,264 |
24-04-24 | 0.2345 | -8.75% | 1,103,880 |
24-04-23 | 0.257 | -1.53% | 373,783 |
24-04-22 | 0.261 | +2.35% | 378,266 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.31% | 3.42M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- YTEN Stock